Growth Metrics

Fulgent Genetics (FLGT) Receivables - Net (2016 - 2026)

Fulgent Genetics' Receivables - Net history spans 12 years, with the latest figure at $69.3 million for Q1 2026.

  • On a quarterly basis, Receivables - Net fell 3.08% to $69.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $69.3 million, a 3.08% decrease, with the full-year FY2025 number at $84.8 million, up 22.81% from a year prior.
  • Receivables - Net hit $69.3 million in Q1 2026 for Fulgent Genetics, down from $84.8 million in the prior quarter.
  • Over the last five years, Receivables - Net for FLGT hit a ceiling of $160.3 million in Q1 2022 and a floor of $13000.0 in Q3 2023.
  • Historically, Receivables - Net has averaged $69.9 million across 5 years, with a median of $69.0 million in 2024.
  • Biggest five-year swings in Receivables - Net: tumbled 99.99% in 2023 and later surged 440784.62% in 2024.
  • Tracing FLGT's Receivables - Net over 5 years: stood at $52.7 million in 2022, then decreased by 3.07% to $51.1 million in 2023, then surged by 34.99% to $69.0 million in 2024, then increased by 22.81% to $84.8 million in 2025, then dropped by 18.27% to $69.3 million in 2026.
  • Business Quant data shows Receivables - Net for FLGT at $69.3 million in Q1 2026, $84.8 million in Q4 2025, and $71.2 million in Q3 2025.